{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:13:22Z","timestamp":1790709202214,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T00:00:00Z","timestamp":1250726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s00210-009-0445-5","type":"journal-article","created":{"date-parts":[[2009,8,19]],"date-time":"2009-08-19T08:37:37Z","timestamp":1250671057000},"page":"421-430","source":"Crossref","is-referenced-by-count":27,"title":["Phosphodiesterases do not limit \u03b21-adrenoceptor-mediated sinoatrial tachycardia: evidence with PDE3 and PDE4 in rabbits and PDE1\u20135 in rats"],"prefix":"10.1007","volume":"380","author":[{"given":"Alberto J.","family":"Kaumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Galindo-Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,20]]},"reference":[{"key":"445_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","volume":"58","author":"AT Bender","year":"2006","unstructured":"Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488\u2013520","journal-title":"Pharmacol Rev"},{"key":"445_CR2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/hh1201.092095","volume":"88","author":"KY Boganov","year":"2001","unstructured":"Boganov KY, Vinogradova TM, Lakatta EG (2001) Sinoatrial nodal cell ryanodine receptor and Na+\u2013Ca2+ exchanger: molecular partners in pacemaker regulation. Circ Res 88:1254\u20131258","journal-title":"Circ Res"},{"key":"445_CR3","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.105.540500","volume":"112","author":"BA Borlaug","year":"2005","unstructured":"Borlaug BA, Melenovsky V, Marhin T, Fitzgerald P, Kass DA (2005) Sildenafil inhibits \u03b2-adrenergic-stimulated cardiac contractility in humans. Circulation 112:2642\u20132649","journal-title":"Circulation"},{"key":"445_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00210-006-0119-5","volume":"374","author":"T Christ","year":"2006","unstructured":"Christ T, Engel A, Ravens U, Kaumann AJ (2006a) Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through \u03b22-adrenoceptors than the effects of (-)-noradrenaline through \u03b21-adrenoceptors in human atrial myocardium. Naunyn Schmiedeberg\u2019s Arch Pharmacol 374:249\u2013253","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"445_CR5","unstructured":"Christ T, Molenaar P, Galindo-Tovar A, Ravens U, Kaumann AJ (2006b) Contractile response through Gs-coupled receptors are reduced by phosphodiesterase3 activity in human isolated myocardium. Biochem Soc Focusing Meeting. Compartimentalization of cAMP signals. Cambridge UK, 29\u201330 March: P014."},{"key":"445_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1476-5381.2008.00015.x","volume":"156","author":"T Christ","year":"2009","unstructured":"Christ T, Galindo-Tovar A, Thoms M, Ravens U, Kaumann AJ (2009) Phosphodiesterases3- and 4-controlled compartments, activated by \u03b21- and \u03b22-adrenoceptors, differ for L-type Ca2+ current and inotropy in rat heart. Br J Pharmacol 156:62\u201383","journal-title":"Br J Pharmacol"},{"key":"445_CR7","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","volume":"274","author":"JD Corbin","year":"1999","unstructured":"Corbin JD, Francis SH (1999) Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 274:13729\u201313732","journal-title":"J Biol Chem"},{"key":"445_CR8","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1021\/jm030056e","volume":"46","author":"A Daugan","year":"2003","unstructured":"Daugan A, Grondin P, Ruault C, Monnier L, de Gouville A-C, Coste H, Kirilovsky J, Hyafil F, Labaudinire R (2003) The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5, 6, 11, 11a-tetrahydro-1H imidazo[1\u2032, 5\u2032:1, 6]pyrido[3, 4-b]indole-1, 3(2H)-dione analogues. J Med Chem 46:4525\u20134532","journal-title":"J Med Chem"},{"key":"445_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/351145a0","volume":"351","author":"D Di Francesco","year":"1991","unstructured":"Di Francesco D, Tortora P (1991) Direct activation of cardiac pacemaker channels by cyclic AMP. Nature 351:145\u2013147","journal-title":"Nature"},{"key":"445_CR10","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/j.1742-4658.2007.06001.x","volume":"274","author":"TR Dunkern","year":"2007","unstructured":"Dunkern TR, Hatzelmann A (2007) Characterization of inhibitors of phosphodiesterase 1C on a human cellular system. FEBS J 274:4812\u20134824","journal-title":"FEBS J"},{"key":"445_CR11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.RES.0000246118.98832.04","volume":"99","author":"R Fischmeister","year":"2006","unstructured":"Fischmeister R, Castro LRV, Abi-Gerges A, Rochais F, Jurevicius J, Leroy J, Vandecasteele G (2006) Compartmentation of cyclic nucleotide signalling in the heart. The role of cyclic nucleotide phosphodiesterases. Circ Res 99:816\u2013828","journal-title":"Circ Res"},{"key":"445_CR12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/sj.bjp.0707631","volume":"153","author":"A Galindo-Tovar","year":"2008","unstructured":"Galindo-Tovar A, Kaumann AJ (2008) Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac \u03b2-adrenoceptors. Br J Pharmacol 153:710\u2013720","journal-title":"Br J Pharmacol"},{"key":"445_CR13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1476-5381.2008.00023.x","volume":"156","author":"A Galindo-Tovar","year":"2009","unstructured":"Galindo-Tovar A, Vargas ML, Escudero E, Kaumann AJ (2009a) Ontogenic changes of the control by phosphodiesterases-3 and -4 of 5-HT responses in porcine heart and relevance to human atrial 5-HT4 receptors. Br J Pharmacol 156:237\u2013249","journal-title":"Br J Pharmacol"},{"key":"445_CR14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00210-008-0367-7","volume":"379","author":"A Galindo-Tovar","year":"2009","unstructured":"Galindo-Tovar A, Vargas ML, Kaumann AJ (2009b) Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE-evoked sinoatrial bradycardia in rat atrium. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 379:379\u2013384","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"445_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0021-9258(19)75931-6","volume":"262","author":"TW Gettys","year":"1987","unstructured":"Gettys TW, Blackmore PF, Redmon JB, Beebe SJ, Corbin JD (1987) Short-term feedback regulation of cAMP by accelerated degradation in rat tissues. J Biol Chem 262:333\u2013339","journal-title":"J Biol Chem"},{"key":"445_CR16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00498852","volume":"331","author":"E Gille","year":"1985","unstructured":"Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (-)-propranolol for \u03b21- and \u03b22-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn Schmiedeberg\u2019s Arch Pharmacol 331:60\u201370","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"445_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjp.0704700","volume":"136","author":"JF Heubach","year":"2002","unstructured":"Heubach JF, Rau T, Eschenhagen T, Ravens U, Kaumann AJ (2002) Physiological antagonism between ventricular \u03b21-adrenoceptors and \u03b11-adrenoceptors but no evidence for \u03b22- and \u03b23-adrenoceptor function in murine heart. Br J Pharmacol 136:217\u2013229","journal-title":"Br J Pharmacol"},{"key":"445_CR18","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/CIRCRESAHA.107.162511","volume":"101","author":"DA Kass","year":"2007","unstructured":"Kass DA, Champion HC, Beavo JA (2007) Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res 101:1084\u20131095","journal-title":"Circ Res"},{"key":"445_CR19","first-page":"715","volume":"20","author":"Y Katano","year":"1992","unstructured":"Katano Y, Endoh M (1992) Effects of a cardiotonic quinolinone derivative Y-20487 on the positive inotropic action and cyclic AMP-accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20\u20131724, milrinone, and isobutylmethylxanthine. Cardiovasc Pharmacol 20:715\u2013722","journal-title":"Cardiovasc Pharmacol"},{"key":"445_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00210-007-0140-3","volume":"375","author":"AJ Kaumann","year":"2007","unstructured":"Kaumann AJ, Semmler AL, Molenaar P (2007) The effects of both noradrenaline and CGP12177, mediated through human \u03b21-adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells. Naunyn Schmiedeberg\u2019s Arch Pharmacol 375:123\u2013131","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"445_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yjmcc.2009.03.022","volume":"47","author":"EG Lakatta","year":"2009","unstructured":"Lakatta EG, DiFrancesco D (2009) What keeps us ticking: a funny current, a calcium clock, or both? J Mol Cell Cardiol 47:157\u2013170","journal-title":"J Mol Cell Cardiol"},{"key":"445_CR22","first-page":"56","volume":"344","author":"H Lemoine","year":"1992","unstructured":"Lemoine H, Kaumann AJ (1992) Regional differences between \u03b21- and \u03b22-adrenoceptors mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol 344:56\u201369","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"445_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-1119(98)00303-5","volume":"216","author":"K Loughney","year":"1998","unstructured":"Loughney K, Hill TR, Florio VA, Uher L, Rosman GS, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K (1998) Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3\u2019, 5\u2019-cyclic nucleotide phosphodiesterase. Gene 216:139\u2013147","journal-title":"Gene"},{"key":"445_CR24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.bjp.0704743","volume":"136","author":"SJ MacKenzie","year":"2002","unstructured":"MacKenzie SJ, Baillie GS, MacPhee I, MacKenzie C, Seamons R, McSorley T, Millen J, Beard MB, van Heeke G, Houslay MD (2002) Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in upstream conserved region 1 (UCR1). Br J Pharmacol 136:421\u2013433","journal-title":"Br J Pharmacol"},{"key":"445_CR25","first-page":"H594","volume":"296","author":"VA Maltsev","year":"2009","unstructured":"Maltsev VA, Lakatta EG (2009) Synergism of coupled subsarcolemmal Ca2+ clocks and sarcolemmal voltage clocks confer robust and flexible pacemaker function in a novel pacemaker cell model. Am J Physiol 296:H594\u2013H615","journal-title":"Am J Physiol"},{"key":"445_CR26","doi-asserted-by":"crossref","first-page":"26286","DOI":"10.1016\/S0021-9258(19)74313-0","volume":"268","author":"PF M\u00e9ry","year":"1993","unstructured":"M\u00e9ry PF, Belhassen L, Pecker F, Fischmeister R (1993) Nitric oxide regulates cardiac Ca2+ current\u2014involvement of cGMP-inhibited and cGMP-stimulated phoshodiesterases through guanylyl cyclase activation. J Biol Chem 268:26286\u201326295","journal-title":"J Biol Chem"},{"key":"445_CR27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1113\/jphysiol.1991.sp018839","volume":"443","author":"K Ono","year":"1991","unstructured":"Ono K, Trautwein W (1991) Potentiation by cyclic GMP of \u03b2-adrenergic effects of Ca2+ current in guinea-pig ventricular myocytes. J Physiol 443:387\u2013404","journal-title":"J Physiol"},{"key":"445_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10557-007-6014-6","volume":"21","author":"OE Osadchii","year":"2007","unstructured":"Osadchii OE (2007) Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease. Cardiovasc Drugs Ther 21:171\u2013194","journal-title":"Cardiovasc Drugs Ther"},{"key":"445_CR29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0898-6568(95)00042-N","volume":"7","author":"T Podzuweit","year":"1995","unstructured":"Podzuweit T, Nennstiel P, Moller A (1995) An isoenzyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine. Cell Signal 7:733\u2013738","journal-title":"Cell Signal"},{"key":"445_CR30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/j.1939-4640.2004.tb02833.x","volume":"25","author":"G Pomara","year":"2004","unstructured":"Pomara G, Morelli G, Pomara S, Taddei S, Ghiadoni L, Dinelli N, Travaglini F, Dicuio M, Mandaini N, Salvetti A, Selli C (2004) Cardiovascular parameter changes in patients with erectile dysfunction using Pde-5 inhibitors: a study with sildenafil and vardenafil. J Androl 25:625\u2013629","journal-title":"J Androl"},{"key":"445_CR31","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1096\/fj.00-0538com","volume":"15","author":"H Senzaki","year":"2001","unstructured":"Senzaki H, Smith CJ, Juang GJ, Isoda T, Mayer SP, Ohler A, Paolocci N, Tomaselli GF, Hare JM, Kass DA (2001) Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signalling in vivo and is down-regulated in heart failure. FASEB J 15:1718\u20131726","journal-title":"FASEB J"},{"key":"445_CR32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1476-5381.1991.tb12453.x","volume":"104","author":"M Shahid","year":"1991","unstructured":"Shahid M, van Amsterdam RGM, de Boer J, ten Berge RE, Nicholson CD, Zaagsma J (1991) The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and thefunctional effects of selective inhibitors. Br J Pharmacol 104:471\u2013477","journal-title":"Br J Pharmacol"},{"key":"445_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1023\/A:1022186402442","volume":"16","author":"Y Shakur","year":"2002","unstructured":"Shakur Y, Fong M, Hensley J, Cone J, Movsesian MA, Kambayashi J, Yoshitake M, Liu Y (2002) Comparison of the effects of cilostazol and milrinone on cAMP-PDE activity, intracellular cAMP and calcium in the heart. Cardiovasc Drugs Ther 16:417\u2013426","journal-title":"Cardiovasc Drugs Ther"},{"key":"445_CR34","doi-asserted-by":"crossref","first-page":"13385","DOI":"10.1016\/S0021-9258(18)98851-4","volume":"266","author":"CJ Smith","year":"1991","unstructured":"Smith CJ, Vasta V, Degerman E, Belfrage P, Manganiello VC (1991) Hormone sensitive cyclic GMP-inhibited cylic AMP phosphodiesterases in rat adipocytes. J Biol Chem 266:13385\u201313390","journal-title":"J Biol Chem"},{"key":"445_CR35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.1998.8769","volume":"247","author":"P Stacey","year":"1998","unstructured":"Stacey P, Rulten S, Dapling A, Phillips SC (1998) Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5). Biochem Biophys Res Commun 247:249\u2013254","journal-title":"Biochem Biophys Res Commun"},{"key":"445_CR36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0006-2952(99)00346-9","volume":"59","author":"T Sudo","year":"2000","unstructured":"Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H (2000) Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochem Pharmacol 59:347\u2013356","journal-title":"Biochem Pharmacol"},{"key":"445_CR37","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00005344-200112000-00016","volume":"38","author":"A Sugiyama","year":"2001","unstructured":"Sugiyama A, Satoh Y, Shiina H, Takahara A, Yoneyama M, Hashimoto K (2001) Cardiac electrophsiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs. J Cardiovasc Pharmacol 38:940\u2013946","journal-title":"J Cardiovasc Pharmacol"},{"key":"445_CR38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1254\/jjp.88.362","volume":"88","author":"A Sugiyama","year":"2002","unstructured":"Sugiyama A, Takeuchi N, Saegusa Y, Sugita M, Hashimoto K (2002) Molecular mechanism of cardiostimulatory effects of sildenafil. Jpn J Pharmacol 88:362\u2013364","journal-title":"Jpn J Pharmacol"},{"key":"445_CR39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.RES.0000152262.22968.72","volume":"96","author":"E Takimoto","year":"2005","unstructured":"Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, ISO T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA (2005) cGMP catabolism by phosphodiestrase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism. Circ Res 96:100\u2013109","journal-title":"Circ Res"},{"key":"445_CR40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1098\/rspb.1996.0038","volume":"263","author":"H Tanaka","year":"1996","unstructured":"Tanaka H, Clark RB, Giles WR (1996) Positive chronotropic responses of rabbit sino-atrial node cells to flash-photolysis of caged isoproterenol and cyclic AMP. Proc Biol Sci 263:241\u2013248","journal-title":"Proc Biol Sci"},{"key":"445_CR41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-3565(25)30907-9","volume":"201","author":"T Taniguchi","year":"1977","unstructured":"Taniguchi T, Fujiwara M, Ohsumi K (1977) Possible involvement of cyclic adenosine 3\u2032:5\u2032-monophosphate in the genesis of catecholamine-induced tachycardia in isolated rabbit sinoatrial node. J Pharmacol Exp Ther 201:678\u2013688","journal-title":"J Pharmacol Exp Ther"},{"key":"445_CR42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/jm980314l","volume":"42","author":"T Ukita","year":"1999","unstructured":"Ukita T, Sugahara M, Terakawa Y, Kuroda T, Wada K, Nakata A, Ohmachi Y, Kikkawa H, Ikezawa K, Naito K (1999) Novel, potent, and selective phosphodiesterase-4 inhibitors as antiasthmatic agents: synthesis and biological activities of a series of 1-pyridylnaphthalene derivatives. J Med Chem 42:1088\u20131099","journal-title":"J Med Chem"},{"key":"445_CR43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.bjp.0706498","volume":"147","author":"ML Vargas","year":"2006","unstructured":"Vargas ML, Hernandez J, Kaumann AJ (2006) Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle. Br J Pharmacol 147:158\u2013163","journal-title":"Br J Pharmacol"},{"key":"445_CR44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjp.0702506","volume":"127","author":"I Verde","year":"1999","unstructured":"Verde I, Vandecasteele G, Lezoualc\u2019h F, Fischmeister R (1999) Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the Ca2+ current in rat ventricular myocytes. Br J Pharmacol 127:65\u201374","journal-title":"Br J Pharmacol"},{"key":"445_CR45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/01.RES.0000204575.94040.d1","volume":"98","author":"TM Vinogradova","year":"2006","unstructured":"Vinogradova TM, Lyashkov AE, Zhu W, Ruknudin AM, Sirenko S, Yang D, Deo S, Barlow M, Johnson S, Caffrey JL, Zhou Y-Y, Xiao R-P, Cheng H, Stern MD, Maltsev VA, Lakatta EG (2006) High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells. Circ Res 98:505\u2013514","journal-title":"Circ Res"},{"key":"445_CR46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/CIRCRESAHA.107.161679","volume":"102","author":"TM Vinogradova","year":"2008","unstructured":"Vinogradova TM, Sirenko S, Lyashkov AE, Younes A, Li Y, Zhu W, Yang D, Ruknudin AM, Spurgeon H, Lakatta EG (2008) Constitutive phosphodiesterase activity restricts spontaneous beating rate of cardiac pacemaker cells by suppressing local Ca2+ releases. Circ Res 102:761\u2013769","journal-title":"Circ Res"},{"key":"445_CR47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yjmcc.2009.03.021","volume":"47","author":"H Wang","year":"2009","unstructured":"Wang H, Kohr MJ, Traynham CJ, Ziolo MT (2009) Phosphodiesterase 5 restricts NOS3\/soluble guanylate cyclase signalling to L-type Ca2+ current in cardiac myocytes. J Mol Cell Cardiol 47:304\u2013314","journal-title":"J Mol Cell Cardiol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-009-0445-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-009-0445-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-009-0445-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:53:05Z","timestamp":1739303585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-009-0445-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,20]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1007\/s00210-009-0445-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,20]]}}}